The multi-scale models envisioned by MC-START are predicated on the ability to share the latest measurements and data produced by the various research projects and integrate them into multi-scale models. To achieve this objective, we must have the ability to publish, discover, and retrieve data from the research projects and integrate them into multi-scale models must become a regular occurrence, not an exceptional event. For the results of these models to be scientifically valid, it is not simply enough to be able to access the underlying data, but we must be able to account for the details of its production, to record the provenance of both in vivo and model based data production, so as to enable repeatability, and to explore alternative formulations of the models is a methodical and structured approach. Furthermore, we must have a means by which computational models can be published and made both across the participations in MC-START and also eventually to the research community at large. It must be possible for members of one research project to have the ability so execute models produced by another research project, combining them to form the multi-scale models that are the underpinning of MC-START.

Public Health Relevance

MC-START is structured around a set of interconnected research projects that are looking at tumor behavior from a variety of perspectives. As a consequence, the results are heterogeneous sets of data that need to be combined into integrated multi-scale models that form the unique perspective and approach proposed by MC-START. This project provides this essential infrastructure required to create the integrated model,

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143907-02
Application #
8182436
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$132,332
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Ng, Chin F; Frieboes, Hermann B (2018) Simulation of Multispecies Desmoplastic Cancer Growth via a Fully Adaptive Non-linear Full Multigrid Algorithm. Front Physiol 9:821
Tipton, Laura; Müller, Christian L; Kurtz, Zachary D et al. (2018) Fungi stabilize connectivity in the lung and skin microbial ecosystems. Microbiome 6:12
Lee, Jung-Rok; Appelmann, Iris; Miething, Cornelius et al. (2018) Longitudinal Multiplexed Measurement of Quantitative Proteomic Signatures in Mouse Lymphoma Models Using Magneto-Nanosensors. Theranostics 8:1389-1398
Tennill, Thomas A; Gross, Mitchell E; Frieboes, Hermann B (2017) Automated analysis of co-localized protein expression in histologic sections of prostate cancer. PLoS One 12:e0178362
Ware, Matthew J; Curtis, Louis T; Wu, Min et al. (2017) Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach. Sci Rep 7:3437
Ng, Chin F; Frieboes, Hermann B (2017) Model of vascular desmoplastic multispecies tumor growth. J Theor Biol 430:245-282
Garvey, Colleen M; Gerhart, Torin A; Mumenthaler, Shannon M (2017) Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques. J Vis Exp :
Lee, Jung-Rok; Chan, Carmel T; Ruderman, Daniel et al. (2017) Longitudinal Monitoring of Antibody Responses against Tumor Cells Using Magneto-nanosensors with a Nanoliter of Blood. Nano Lett 17:6644-6652
Yan, Huaming; Romero-Lopez, Monica; Frieboes, Hermann B et al. (2017) Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness. IEEE Trans Biomed Eng 64:538-548
Yan, Huaming; Romero-López, Mónica; Benitez, Lesly I et al. (2017) 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. Cancer Res 77:4171-4184

Showing the most recent 10 out of 128 publications